Rab25 and CLIC3 collaborate to promote integrin recycling from late endosomes/lysosomes and drive cancer progression

Here we show that Rab25 permits the sorting of ligand-occupied, active-conformation α5β1 integrin to late endosomes/lysosomes. Photoactivation and biochemical approaches show that lysosomally targeted integrins are not degraded but are retrogradely transported and recycled to the plasma membrane at...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Developmental cell Ročník 22; číslo 1; s. 131
Hlavní autoři: Dozynkiewicz, Marta A, Jamieson, Nigel B, Macpherson, Iain, Grindlay, Joan, van den Berghe, Peter V E, von Thun, Anne, Morton, Jennifer P, Gourley, Charlie, Timpson, Paul, Nixon, Colin, McKay, Colin J, Carter, Ross, Strachan, David, Anderson, Kurt, Sansom, Owen J, Caswell, Patrick T, Norman, Jim C
Médium: Journal Article
Jazyk:angličtina
Vydáno: United States 17.01.2012
Témata:
ISSN:1878-1551, 1878-1551
On-line přístup:Zjistit podrobnosti o přístupu
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
Abstract Here we show that Rab25 permits the sorting of ligand-occupied, active-conformation α5β1 integrin to late endosomes/lysosomes. Photoactivation and biochemical approaches show that lysosomally targeted integrins are not degraded but are retrogradely transported and recycled to the plasma membrane at the back of invading cells. This requires CLIC3, a protein upregulated in Rab25-expressing cells and tumors, which colocalizes with active α5β1 in late endosomes/lysosomes. CLIC3 is necessary for release of the cell rear during migration on 3D matrices and is required for invasion and maintenance of active Src signaling in organotypic microenvironments. CLIC3 expression predicts lymph node metastasis and poor prognosis in operable cases of pancreatic ductal adenocarcinoma (PDAC). The identification of CLIC3 as a regulator of a recycling pathway and as an independent prognostic indicator in PDAC highlights the importance of active integrin trafficking as a potential drive to cancer progression in vivo.
AbstractList Here we show that Rab25 permits the sorting of ligand-occupied, active-conformation α5β1 integrin to late endosomes/lysosomes. Photoactivation and biochemical approaches show that lysosomally targeted integrins are not degraded but are retrogradely transported and recycled to the plasma membrane at the back of invading cells. This requires CLIC3, a protein upregulated in Rab25-expressing cells and tumors, which colocalizes with active α5β1 in late endosomes/lysosomes. CLIC3 is necessary for release of the cell rear during migration on 3D matrices and is required for invasion and maintenance of active Src signaling in organotypic microenvironments. CLIC3 expression predicts lymph node metastasis and poor prognosis in operable cases of pancreatic ductal adenocarcinoma (PDAC). The identification of CLIC3 as a regulator of a recycling pathway and as an independent prognostic indicator in PDAC highlights the importance of active integrin trafficking as a potential drive to cancer progression in vivo.Here we show that Rab25 permits the sorting of ligand-occupied, active-conformation α5β1 integrin to late endosomes/lysosomes. Photoactivation and biochemical approaches show that lysosomally targeted integrins are not degraded but are retrogradely transported and recycled to the plasma membrane at the back of invading cells. This requires CLIC3, a protein upregulated in Rab25-expressing cells and tumors, which colocalizes with active α5β1 in late endosomes/lysosomes. CLIC3 is necessary for release of the cell rear during migration on 3D matrices and is required for invasion and maintenance of active Src signaling in organotypic microenvironments. CLIC3 expression predicts lymph node metastasis and poor prognosis in operable cases of pancreatic ductal adenocarcinoma (PDAC). The identification of CLIC3 as a regulator of a recycling pathway and as an independent prognostic indicator in PDAC highlights the importance of active integrin trafficking as a potential drive to cancer progression in vivo.
Here we show that Rab25 permits the sorting of ligand-occupied, active-conformation α5β1 integrin to late endosomes/lysosomes. Photoactivation and biochemical approaches show that lysosomally targeted integrins are not degraded but are retrogradely transported and recycled to the plasma membrane at the back of invading cells. This requires CLIC3, a protein upregulated in Rab25-expressing cells and tumors, which colocalizes with active α5β1 in late endosomes/lysosomes. CLIC3 is necessary for release of the cell rear during migration on 3D matrices and is required for invasion and maintenance of active Src signaling in organotypic microenvironments. CLIC3 expression predicts lymph node metastasis and poor prognosis in operable cases of pancreatic ductal adenocarcinoma (PDAC). The identification of CLIC3 as a regulator of a recycling pathway and as an independent prognostic indicator in PDAC highlights the importance of active integrin trafficking as a potential drive to cancer progression in vivo.
Author Sansom, Owen J
Dozynkiewicz, Marta A
Norman, Jim C
Strachan, David
Carter, Ross
Nixon, Colin
McKay, Colin J
van den Berghe, Peter V E
Morton, Jennifer P
Jamieson, Nigel B
Macpherson, Iain
Caswell, Patrick T
Anderson, Kurt
von Thun, Anne
Grindlay, Joan
Gourley, Charlie
Timpson, Paul
Author_xml – sequence: 1
  givenname: Marta A
  surname: Dozynkiewicz
  fullname: Dozynkiewicz, Marta A
  organization: Beatson Institute for Cancer Research, Garscube Estate, Glasgow G61 1BD, UK
– sequence: 2
  givenname: Nigel B
  surname: Jamieson
  fullname: Jamieson, Nigel B
– sequence: 3
  givenname: Iain
  surname: Macpherson
  fullname: Macpherson, Iain
– sequence: 4
  givenname: Joan
  surname: Grindlay
  fullname: Grindlay, Joan
– sequence: 5
  givenname: Peter V E
  surname: van den Berghe
  fullname: van den Berghe, Peter V E
– sequence: 6
  givenname: Anne
  surname: von Thun
  fullname: von Thun, Anne
– sequence: 7
  givenname: Jennifer P
  surname: Morton
  fullname: Morton, Jennifer P
– sequence: 8
  givenname: Charlie
  surname: Gourley
  fullname: Gourley, Charlie
– sequence: 9
  givenname: Paul
  surname: Timpson
  fullname: Timpson, Paul
– sequence: 10
  givenname: Colin
  surname: Nixon
  fullname: Nixon, Colin
– sequence: 11
  givenname: Colin J
  surname: McKay
  fullname: McKay, Colin J
– sequence: 12
  givenname: Ross
  surname: Carter
  fullname: Carter, Ross
– sequence: 13
  givenname: David
  surname: Strachan
  fullname: Strachan, David
– sequence: 14
  givenname: Kurt
  surname: Anderson
  fullname: Anderson, Kurt
– sequence: 15
  givenname: Owen J
  surname: Sansom
  fullname: Sansom, Owen J
– sequence: 16
  givenname: Patrick T
  surname: Caswell
  fullname: Caswell, Patrick T
– sequence: 17
  givenname: Jim C
  surname: Norman
  fullname: Norman, Jim C
BackLink https://www.ncbi.nlm.nih.gov/pubmed/22197222$$D View this record in MEDLINE/PubMed
BookMark eNpNUMtqwzAQFCWlebR_UIpuPTmRFMmSj8X0EQgUSu5GttbBQZZSyQnk76s0KRQWdtidnWFnikbOO0DokZI5JTRf7OYGjg3YOSOUzlMRom7QhCqpMioEHf3DYzSNcUfSGVXkDo0Zo4VkjE3Q8KVrJrB2BpfrVbnEjbdW1z7oAfDg8T743ifYuQG2oXM4QHNqbOe2uE0rbM88cMZH30Nc2FO8oF9FE7oj4Ea7BsJZaRsgxs67e3Tbahvh4dpnaPP2uik_svXn-6p8WWeNKOiQtTkA4wYKzUR6WbRSt8WyLtKYaym5aZnK8yJXzPBGc11zEEshgNJcKiXZDD1fZJP19wHiUPVdTIlZ7cAfYlVQKSQnnCXm05V5qHsw1T50vQ6n6i8n9gOL-m7t
CitedBy_id crossref_primary_10_1158_1078_0432_CCR_12_2858
crossref_primary_10_1038_cr_2012_110
crossref_primary_10_1002_bies_201200160
crossref_primary_10_1016_j_tcb_2015_02_008
crossref_primary_10_1038_nrc3601
crossref_primary_10_1111_jcmm_12403
crossref_primary_10_1016_j_lfs_2020_118662
crossref_primary_10_1002_mc_22528
crossref_primary_10_1016_j_csbj_2022_08_016
crossref_primary_10_1007_s12195_020_00632_1
crossref_primary_10_1016_j_bbamem_2013_05_025
crossref_primary_10_1016_j_placenta_2012_06_011
crossref_primary_10_1042_BST20120199
crossref_primary_10_1002_1873_3468_13766
crossref_primary_10_3892_ol_2019_9973
crossref_primary_10_1016_j_ebiom_2025_105814
crossref_primary_10_3389_fcell_2024_1444953
crossref_primary_10_1083_jcb_201710051
crossref_primary_10_1016_j_jmb_2014_07_003
crossref_primary_10_1016_j_ejca_2013_03_016
crossref_primary_10_1038_ncomms12111
crossref_primary_10_1126_sciadv_adu6361
crossref_primary_10_1016_j_ceb_2016_02_009
crossref_primary_10_1242_jcs_126573
crossref_primary_10_1051_e3sconf_202124503050
crossref_primary_10_3390_ijms18010189
crossref_primary_10_3389_fcell_2020_597608
crossref_primary_10_1074_jbc_M115_683557
crossref_primary_10_1111_tra_12679
crossref_primary_10_1016_j_canlet_2024_216901
crossref_primary_10_1038_s41467_018_03226_8
crossref_primary_10_1242_jcs_233387
crossref_primary_10_1038_s41556_018_0223_z
crossref_primary_10_3390_ijms21155580
crossref_primary_10_1111_cpr_12592
crossref_primary_10_1158_0008_5472_CAN_12_1269
crossref_primary_10_1016_j_cub_2012_06_060
crossref_primary_10_1016_j_tcb_2018_12_005
crossref_primary_10_1074_jbc_M112_407718
crossref_primary_10_1242_jcs_243683
crossref_primary_10_1007_s42977_022_00120_9
crossref_primary_10_1042_EBC20190012
crossref_primary_10_1080_21541248_2017_1397833
crossref_primary_10_3389_fcell_2022_920303
crossref_primary_10_1016_j_bbapap_2013_09_005
crossref_primary_10_1038_nrm3599
crossref_primary_10_3389_fonc_2022_777634
crossref_primary_10_1091_mbc_e12_10_0745
crossref_primary_10_1158_1541_7786_MCR_14_0249
crossref_primary_10_1016_j_cellsig_2013_03_022
crossref_primary_10_1158_0008_5472_CAN_12_4545
crossref_primary_10_1186_s13072_018_0239_4
crossref_primary_10_1083_jcb_202006049
crossref_primary_10_3390_cancers14040856
crossref_primary_10_1093_carcin_bgu108
crossref_primary_10_3390_ijms23179994
crossref_primary_10_1042_EBC20190025
crossref_primary_10_1016_j_cub_2015_09_049
crossref_primary_10_3390_cancers9070078
crossref_primary_10_1016_j_ceb_2012_08_004
crossref_primary_10_1242_jcs_218925
crossref_primary_10_1016_j_bbamcr_2016_11_020
crossref_primary_10_1038_ncomms14206
crossref_primary_10_1242_jcs_135947
crossref_primary_10_1038_ncb3250
crossref_primary_10_1042_BST20160159
crossref_primary_10_1155_2021_3385058
crossref_primary_10_1038_nprot_2017_107
crossref_primary_10_1091_mbc_E15_04_0257
crossref_primary_10_1242_jcs_254631
crossref_primary_10_1016_j_canlet_2024_216953
crossref_primary_10_1016_j_compbiolchem_2015_09_012
crossref_primary_10_1038_s42003_025_07482_5
crossref_primary_10_3389_fimmu_2024_1445239
crossref_primary_10_1038_s41467_017_00227_x
crossref_primary_10_1242_jcs_155663
crossref_primary_10_1038_ncomms10412
crossref_primary_10_1038_s41418_022_01039_3
crossref_primary_10_1016_j_oraloncology_2015_09_010
crossref_primary_10_1159_000544115
crossref_primary_10_1242_jcs_190835
crossref_primary_10_1371_journal_pone_0211727
crossref_primary_10_1158_0008_5472_CAN_15_2782
crossref_primary_10_3389_fphar_2020_568993
crossref_primary_10_1186_s13046_019_1343_4
crossref_primary_10_1158_0008_5472_CAN_16_3403
crossref_primary_10_1016_j_ijbiomac_2024_130245
crossref_primary_10_1007_s12672_025_02882_9
crossref_primary_10_1016_j_devcel_2020_10_011
crossref_primary_10_1242_jcs_161653
crossref_primary_10_1007_s10456_022_09840_x
crossref_primary_10_1159_000443180
crossref_primary_10_3892_mmr_2021_12269
crossref_primary_10_1038_ncomms8164
crossref_primary_10_1242_jcs_196287
crossref_primary_10_1038_s42003_025_08408_x
crossref_primary_10_1002_path_5311
crossref_primary_10_1007_s00018_022_04371_6
crossref_primary_10_3390_cancers14194890
crossref_primary_10_1124_jpet_120_000379
crossref_primary_10_1186_s40659_017_0107_x
crossref_primary_10_1074_jbc_RA118_002779
crossref_primary_10_1080_21541248_2015_1050152
crossref_primary_10_3390_jcm8060862
crossref_primary_10_1038_srep26413
crossref_primary_10_1016_j_phrs_2024_107084
crossref_primary_10_1074_jbc_R116_715193
crossref_primary_10_1002_jhbp_246
crossref_primary_10_3390_cancers11111783
crossref_primary_10_3390_cancers13122863
crossref_primary_10_7554_eLife_20417
crossref_primary_10_1007_s13277_016_5207_7
crossref_primary_10_1038_s41598_019_48438_0
crossref_primary_10_1002_cam4_153
crossref_primary_10_1158_1541_7786_MCR_12_0300
crossref_primary_10_1016_j_tcb_2016_02_001
crossref_primary_10_1111_acel_13431
crossref_primary_10_1002_dneu_22608
crossref_primary_10_1002_JLB_1MA0420_635R
crossref_primary_10_1016_j_tcb_2012_02_002
crossref_primary_10_1093_carcin_bgt187
crossref_primary_10_3892_etm_2014_1867
crossref_primary_10_1016_j_tcb_2014_02_004
crossref_primary_10_1016_j_ceb_2013_05_008
crossref_primary_10_1016_j_devcel_2015_02_011
crossref_primary_10_1242_jcs_150623
crossref_primary_10_1080_14686996_2018_1444318
crossref_primary_10_1111_tra_12605
crossref_primary_10_1111_tra_12165
crossref_primary_10_1038_s41419_022_05338_y
crossref_primary_10_3389_fonc_2025_1513360
crossref_primary_10_3390_biology10010026
crossref_primary_10_1242_jcs_164459
crossref_primary_10_7717_peerj_8348
crossref_primary_10_1083_jcb_201902073
crossref_primary_10_1242_jcs_207019
crossref_primary_10_3390_v8030064
crossref_primary_10_1038_s41467_017_00888_8
crossref_primary_10_1128_JVI_01819_19
crossref_primary_10_1083_jcb_201502040
crossref_primary_10_1038_s41580_019_0185_4
crossref_primary_10_3748_wjg_v25_i38_5732
crossref_primary_10_1038_s41419_023_06373_z
crossref_primary_10_1038_emm_2017_248
crossref_primary_10_1080_15548627_2018_1450020
crossref_primary_10_1242_jcs_173708
crossref_primary_10_1016_j_bbrc_2015_01_144
crossref_primary_10_3390_cancers10120507
crossref_primary_10_1016_j_jbc_2023_105349
crossref_primary_10_1093_infdis_jiy460
crossref_primary_10_1242_jcs_189431
crossref_primary_10_1083_jcb_202009028
crossref_primary_10_1242_jcs_189795
crossref_primary_10_1038_s41467_017_00646_w
crossref_primary_10_1007_s12272_019_01129_w
crossref_primary_10_3390_cancers13071711
crossref_primary_10_1016_j_bbamem_2014_12_016
crossref_primary_10_1186_s12929_022_00837_8
crossref_primary_10_1038_bjc_2015_28
crossref_primary_10_1002_eji_201242997
crossref_primary_10_3389_fcell_2019_00302
crossref_primary_10_1007_s13277_015_3251_3
crossref_primary_10_3389_fonc_2021_669746
crossref_primary_10_1186_s12576_020_00740_7
crossref_primary_10_1002_jbm4_10003
crossref_primary_10_1083_jcb_201703037
crossref_primary_10_1016_j_semcdb_2017_11_024
crossref_primary_10_3233_CBM_220214
crossref_primary_10_1042_BST20140313
crossref_primary_10_1186_s13578_020_00489_x
crossref_primary_10_1242_jcs_137281
crossref_primary_10_3389_fgene_2022_828373
crossref_primary_10_1016_j_jbc_2025_110716
crossref_primary_10_3389_fncel_2020_556461
crossref_primary_10_1016_j_biocel_2015_11_015
crossref_primary_10_1016_j_tranon_2021_101258
crossref_primary_10_1111_pcmr_12506
crossref_primary_10_1172_JCI133525
crossref_primary_10_1042_BST20120157
crossref_primary_10_1016_j_neo_2023_100924
crossref_primary_10_1158_1541_7786_MCR_14_0353
crossref_primary_10_1083_jcb_201203025
crossref_primary_10_3390_ijms23137206
crossref_primary_10_1002_dneu_22427
crossref_primary_10_1371_journal_pone_0184308
crossref_primary_10_1016_j_csbj_2022_12_040
crossref_primary_10_3390_cancers5020334
crossref_primary_10_1042_BST20190309
crossref_primary_10_1080_15384101_2017_1377031
crossref_primary_10_1038_s41598_020_64396_4
crossref_primary_10_1016_j_ceb_2015_06_009
crossref_primary_10_1242_jcs_260468
crossref_primary_10_1038_s41580_024_00777_1
crossref_primary_10_1042_BST20120145
crossref_primary_10_1093_carcin_bgv052
crossref_primary_10_1038_s41467_018_05578_7
crossref_primary_10_1242_bio_018119
crossref_primary_10_1242_jcs_188490
crossref_primary_10_5772_dmht_09
crossref_primary_10_1002_jcp_25495
crossref_primary_10_1111_tra_12754
crossref_primary_10_1515_revneuro_2017_0110
crossref_primary_10_1371_journal_pone_0199012
crossref_primary_10_1371_journal_pone_0087610
crossref_primary_10_1186_s12931_018_0861_5
crossref_primary_10_3892_mmr_2014_2766
crossref_primary_10_1073_pnas_1400749111
crossref_primary_10_1158_1541_7786_MCR_19_0245
crossref_primary_10_1038_ncb2916
crossref_primary_10_1083_jcb_201302041
crossref_primary_10_1074_jbc_M114_596155
crossref_primary_10_1083_jcb_201111121
crossref_primary_10_1038_s42003_023_04501_1
crossref_primary_10_1083_jcb_202012114
crossref_primary_10_1111_iep_12265
crossref_primary_10_15252_embr_201642032
crossref_primary_10_1007_s13277_015_4606_5
crossref_primary_10_1038_ncomms13546
crossref_primary_10_1042_BST20120249
crossref_primary_10_1016_j_pharmthera_2013_05_007
crossref_primary_10_1371_journal_pone_0131605
crossref_primary_10_1038_s44319_024_00300_9
ContentType Journal Article
Copyright Copyright © 2012 Elsevier Inc. All rights reserved.
Copyright_xml – notice: Copyright © 2012 Elsevier Inc. All rights reserved.
DBID CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1016/j.devcel.2011.11.008
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: 7X8
  name: MEDLINE - Academic
  url: https://search.proquest.com/medline
  sourceTypes: Aggregation Database
DeliveryMethod no_fulltext_linktorsrc
Discipline Biology
EISSN 1878-1551
ExternalDocumentID 22197222
Genre Research Support, Non-U.S. Gov't
Journal Article
GrantInformation_xml – fundername: Cancer Research UK
  grantid: 15565
– fundername: Wellcome Trust
– fundername: Cancer Research UK
  grantid: 12481
– fundername: Chief Scientist Office
  grantid: SCD/11
– fundername: Chief Scientist Office
  grantid: CAF/06/24
GroupedDBID ---
--K
0R~
1~5
2WC
4.4
457
4G.
5GY
5VS
62-
7-5
AAEDT
AAEDW
AAIKJ
AAKRW
AALRI
AAMRU
AAQFI
AAVLU
AAXUO
AAYWO
ABDGV
ABJNI
ABMAC
ACGFO
ACGFS
ACNCT
ADBBV
ADEZE
ADVLN
AEFWE
AENEX
AEXQZ
AFFNX
AFTJW
AGCQF
AGHFR
AGKMS
AITUG
AKAPO
AKRWK
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
APXCP
ASPBG
AVWKF
AZFZN
BAWUL
CGR
CS3
CUY
CVF
D0L
DIK
DU5
E3Z
EBS
ECM
EIF
EJD
F5P
FCP
FDB
FEDTE
FIRID
HVGLF
HZ~
IHE
IXB
J1W
JIG
M3Z
M41
NPM
O-L
O9-
OK1
P2P
RIG
ROL
RPZ
SDG
SES
SSZ
TR2
7X8
ACVFH
ADCNI
AEUPX
AFPUW
AIGII
AKBMS
AKYEP
EFKBS
ID FETCH-LOGICAL-c591t-f6ee24de9a251015f7af93b96ee4a774df28669682d4ca4ab4e5355e11678872
IEDL.DBID 7X8
ISICitedReferencesCount 257
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000299365800015&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 1878-1551
IngestDate Sun Sep 28 08:34:17 EDT 2025
Sat May 31 02:07:52 EDT 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Language English
License Copyright © 2012 Elsevier Inc. All rights reserved.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c591t-f6ee24de9a251015f7af93b96ee4a774df28669682d4ca4ab4e5355e11678872
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink http://www.cell.com/article/S1534580711005181/pdf
PMID 22197222
PQID 917574042
PQPubID 23479
ParticipantIDs proquest_miscellaneous_917574042
pubmed_primary_22197222
PublicationCentury 2000
PublicationDate 2012-01-17
PublicationDateYYYYMMDD 2012-01-17
PublicationDate_xml – month: 01
  year: 2012
  text: 2012-01-17
  day: 17
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Developmental cell
PublicationTitleAlternate Dev Cell
PublicationYear 2012
SSID ssj0016180
Score 2.5162923
Snippet Here we show that Rab25 permits the sorting of ligand-occupied, active-conformation α5β1 integrin to late endosomes/lysosomes. Photoactivation and biochemical...
SourceID proquest
pubmed
SourceType Aggregation Database
Index Database
StartPage 131
SubjectTerms Animals
Antibody Formation
Biological Transport
Blotting, Western
Cell Adhesion
Cell Membrane
Cell Movement - physiology
Cells, Cultured
Chloride Channels - genetics
Chloride Channels - immunology
Chloride Channels - metabolism
Dermis - cytology
Dermis - metabolism
Disease Progression
Endocytosis
Endosomes - physiology
Female
Fibroblasts - cytology
Fibroblasts - metabolism
Humans
Immunoenzyme Techniques
Integrin alpha5beta1 - metabolism
Lysosomes - physiology
Neoplasm Metastasis
Ovarian Neoplasms - metabolism
Ovarian Neoplasms - pathology
Pancreatic Neoplasms - metabolism
Pancreatic Neoplasms - pathology
Protein Transport
rab GTP-Binding Proteins - genetics
rab GTP-Binding Proteins - immunology
rab GTP-Binding Proteins - metabolism
Rabbits
Real-Time Polymerase Chain Reaction
Recycling
RNA, Messenger - genetics
Signal Transduction
Tissue Array Analysis
Title Rab25 and CLIC3 collaborate to promote integrin recycling from late endosomes/lysosomes and drive cancer progression
URI https://www.ncbi.nlm.nih.gov/pubmed/22197222
https://www.proquest.com/docview/917574042
Volume 22
WOSCitedRecordID wos000299365800015&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText
inHoldings 1
isFullTextHit
isPrint
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1LS8NAEF7UKnjx_agv9uA11Gw32exJpFgUtBTpobewyU6kUJPaxEL_vTOb1J7Eg5cQQjaEnUe-zXw7H2O3EYYMpv7QC42WtECxGHMm87Q2CKAVhIlNndiEGgyi8VgPG25O2dAqVznRJWpbpPSPvIPLikBJdLH72adHolFUXG0UNDZZq4tIhhhdarwuIoS-E07zI1ooITJY7Zxz9C4LixSmdQ9PauN5F_2OMd23pr__z7c8YHsNyOQPtVccsg3Ij9hOLTu5PGbVm0lEwE1uee_ludfla2cAXhV85ih6wOtWEpOcY1Zc0hbKd067UfiU7oPcFmXxAWVnuizrM_dEO8f8yVNypjl37K-688cJG_UfR70nr1Ff8NJA-5WXhQBCWtBGUNwGGZpQdxONl6VB0GgzEYXUWkdYmRppEgkBghegwg5mLnHKtvIih3PG0eSgbCZtkoJUBgzQhxOMSnCk0mGb8dVkxujcVLEwORRfZfwznW12VhskntVNOGIhSDBNiIu_B1-yXTQzMVA8X12xVoaBDddsO11Uk3J-45wGj4Ph6zdhAs4p
linkProvider ProQuest
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Rab25+and+CLIC3+collaborate+to+promote+integrin+recycling+from+late+endosomes%2Flysosomes+and+drive+cancer+progression&rft.jtitle=Developmental+cell&rft.au=Dozynkiewicz%2C+Marta+A&rft.au=Jamieson%2C+Nigel+B&rft.au=Macpherson%2C+Iain&rft.au=Grindlay%2C+Joan&rft.date=2012-01-17&rft.eissn=1878-1551&rft.volume=22&rft.issue=1&rft.spage=131&rft_id=info:doi/10.1016%2Fj.devcel.2011.11.008&rft_id=info%3Apmid%2F22197222&rft_id=info%3Apmid%2F22197222&rft.externalDocID=22197222
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1878-1551&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1878-1551&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1878-1551&client=summon